The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a ...

Gene therapy, a technique that is revolutionizing the treatment of multiple genetic conditions, including eye and muscle ...

The new nasal vaccine only needs one dose and produces reliable immunity right at the site where the virus enters the body.

Patient associations are shaping trials, asking hard questions, and demanding realistic timelines for treatment delivery.

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

How to design and launch a successful Clinical Trial Manufacturing.

Apr. 8, 2025 — Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic ...

Built around one of the most prolific academic viral vector manufacturing teams, ViroCell was created to address the global demand for precisely engineered viral vectors. The team leverages its ...

Novartis has strengthened its presence in Slovenia following the official opening in February 2025 of a new viral vector production facility (VIFA One) in Mengeš. Novartis invested €40 million (US$43 ...

The combination of synchronous experimental process development and digital twin core model development is among the first of its kind.